Case Report
Accepted on 29 May 2025
Successful Management of Acute Promyelocytic Leukemia in the Third Trimester of pregnancy: Case report and Review of Literature
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1553336
- Frontiers in Hematology
- Blood Cancer
- Articles
Type at least 3 characters
62 articles
Mini Review
Accepted on 26 May 2025
Understanding Therapy-Related AML: Genetic Insights and Emerging Strategies for High-Risk Patients
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1609642
- 121 views
Original Research
Published on 23 May 2025
Downregulated PTEN and aberrant JAK–STAT signal pathway in essential thrombocythemia patients
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1479185
- 338 views
Case Report
Accepted on 22 May 2025
Contrasting outcomes and use of desmosine to monitor two patients treated with plasma cell directed chemotherapy for gammopathy driven pulmonary elastolysis in acquired cutis laxa
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1502322
Original Research
Published on 14 May 2025
Mogamulizumab in combination improves clinical outcomes in relapsed and refractory Sézary syndrome
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1557641
- 431 views
Mini Review
Published on 13 May 2025
Not just for mature audiences: myeloproliferative neoplasms in children, adolescents, and young adults
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1483322
- 293 views
Original Research
Published on 06 May 2025
Disease and treatment burden in patients with leukaemia: family members/partner perspective
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1570055
- 473 views
Clinical Trial
Published on 22 Apr 2025
Preliminary clinical activity of TP-0903 in relapsed or refractory acute myeloid leukemia with FLT3-ITD mutations
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1554764
- 516 views
Review
Published on 21 Mar 2025
Exercise and diet studies among patients living with multiple myeloma: current evidence and considerations of patient preferences
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1550681
- 1,040 views
Case Report
Published on 04 Mar 2025
Case Report: Triplet combination with pirtobrutinib/venetoclax/rituximab in accelerated phase of chronic lymphocytic leukemia
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1552200
- 818 views
Review
Published on 03 Mar 2025
Abnormalities of primary and secondary hemostasis in multiple myeloma: insights from studies on thrombopoiesis, the coagulation system, and the bone marrow microenvironment
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1435193
- 873 views
Case Report
Published on 26 Feb 2025
Acquired von Willebrand disease associated with smoldering multiple myeloma and hereditary hemorrhagic telangiectasia successfully treated with daratumumab, pomalidomide, and dexamethasone: hitting three birds with one stone? – case report
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1499500
- 735 views
Original Research
Published on 21 Feb 2025
Time to initiation of antiresorptive agents in multiple myeloma to reduce skeletal related events
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1521017
- 467 views
Original Research
Published on 21 Jan 2025
Impact of leukemia subtype and demographics on patient quality of life in 76 countries: a cross-sectional study
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1502166
- 2,373 views
- 1 citation
Case Report
Published on 16 Jan 2025
Case report: VEXAS syndrome: first documented cases in Latin America
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1501337
- 579 views
Case Report
Published on 10 Jan 2025
Case report: A decade-long journey with cyclic thrombocytopenia
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1482891
- 642 views